Skip to content
Header Image
Market Spectator

Market Spectator

  • Home
  • Terms of Service
  • Privacy Policy
  • Disclaimer
  • Contact Us
  • Home
  • 2024
  • February
  • 16
  • Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost
  • FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant

FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant

FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo

Post navigation

Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • Nvidia’s supply snags limit deliveries even as demand booms
  • Exclusive-Amazon likely to face investigation under EU tech rules next year, sources say
  • Automakers urge Trump to preserve EV tax credits, boost self-driving cars
  • Crypto industry jockeys for seats at Trump’s promised council
  • Elf Beauty stock slides after Muddy Waters says it has shorted its shares

Recent Comments

No comments to show.

Copyright © 2024 Market Spectator | Ace News by Ascendoor | Powered by WordPress.

We use cookies to ensure that we give you the best experience on our website.Ok